Monday, May 14, 2018

David Liu launches Beam Therapeutics to treat genetic diseases with CRISPR base editing

Joined by CRISPR luminaries Feng Zhang and J. Keith Joung, the Harvard chemist raises up to $87 million in funding

via Chemical & Engineering News: Biological SCENE https://ift.tt/2IDbJ60
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)